We are excited to open Spartan’s new headquarters that further expands our research and manufacturing capabilities. -Paul Lem, M.D., CEO of Spartan Bioscience.
Ottawa, Ontario (PRWEB) October 15, 2015
Spartan Bioscience today announced the opening of its new headquarters at 2934 Baseline Road, Suite 500, Ottawa, Canada. The facility contains new research laboratories and expanded manufacturing capabilities.
The ribbon-cutting ceremony featured Mr. Jim Watson, Mayor of Ottawa, and Mr. Joe Adachi, President and CEO of Canon U.S.A. and Chairman of Canon Canada. Other Canon representatives included Mr. Seymour Liebman, executive vice president, chief administrative officer and general counsel of Canon U.S.A., and Ms. Akiko Tanaka, President and CEO of Canon BioMedical. Canon U.S.A. is a strategic investor in Spartan Bioscience, and Mr. Liebman is a member of Spartan’s Board of Directors.
Also in attendance were representatives from the University of Ottawa Heart Institute, Carleton University, and the University of Ottawa. Spartan Bioscience has a long history of successful collaborations with Ottawa’s top academic institutions.
“We are excited to open Spartan’s new headquarters that further expands our research and manufacturing capabilities.” said Paul Lem, M.D., CEO of Spartan Bioscience. “We are grateful to our partners and supporters for helping make this happen.”
About Spartan Bioscience
Spartan Bioscience is the leader in on-demand DNA testing.(1) Spartan is bringing complete sample-to-result DNA testing systems to medicine. Spartan’s technology fully integrates DNA collection, extraction, and analysis, with an intuitive interface that is easy to operate. For the first time, healthcare providers and their patients can get DNA results on demand. For more information, please visit our website at: http://www.spartanbio.com.
1. Roberts JD et al. (2012). Lancet. 379:1705–11.